Adds: Surgery Partners, Nuveen; Updates: Eli Lilly
June 17 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Tuesday:
** Surgery Partners <SGRY.O> said it was unable to agree to the terms set by Bain Capital, its largest shareholder, to take the surgical facility operator private. nL4N3SK0YM
** Eli Lilly <LLY.N> will acquire gene-editing startup Verve Therapeutics <VERV.O> for up to $1.3 billion, the companies said, to boost its pipeline of experimental medicines beyond its blockbuster weight-loss and diabetes drugs. nL4N3SJ1JV
** Nuveen said it is acquiring Brooklyn Investment Group and its parent technology company, as the asset manager looks to expand its footprint in direct indexing, a fast-growing area of the investment management industry. nL4N3SJ1IU
** London-listed venture capital investor BP Marsh has acquired a 27% shareholding in Cameron Specialty, a London-based specialty MGA. nL6N3SK0DF
** Private equity firm KKR <KKR.N> said it had agreed to acquire Australian power producer Zenith Energy from a consortium comprising Australia-based Pacific Equity Partners, Canada's OPSEU Pension Trust and London-listed Foresight Group <FSGF.L>. nL4N3SJ1GP
(Compiled by Rajarshi Roy and Padmanabhan Ananthan in Bengaluru)
((Padmanabhan.Ananthan@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。